Télécharger le supplément (250 p.) - KCE

More documents

Recommendations

Info

110 Médecine à l'acte / médecine au forfait - ANNEXES KCE Reports 85 S Parameter Estimate Standard Error t Value Pr > |t| age*im 85-+ ans 2 0.000000 B . . . age*inv 1-4 ans 1 -3517.913759 B 2875.459754 -1.22 0.2212 age*inv 1-4 ans 2 0.000000 B . . . age*inv 25-39 ans 1 3567.222880 B 2245.576768 1.59 0.1122 age*inv 25-39 ans 2 0.000000 B . . . age*inv 40-64 ans 1 -98.248001 B 2217.280270 -0.04 0.9647 age*inv 40-64 ans 2 0.000000 B . . . age*inv 5-24 ans 1 -3145.578857 B 2227.249572 -1.41 0.1579 age*inv 5-24 ans 2 0.000000 B . . . age*inv 65-74 ans 1 1647.680954 B 2993.542480 0.55 0.5820 age*inv 65-74 ans 2 0.000000 B . . . age*inv 75-84 ans 1 0.000000 B . . . age*inv 75-84 ans 2 0.000000 B . . . age*inv 85-+ ans 2 0.000000 B . . . im*chom3 1 1 -1243.585233 B 330.146326 -3.77 0.0002 im*chom3 1 2 0.000000 B . . . im*chom3 2 1 0.000000 B . . . im*chom3 2 2 0.000000 B . . . inv*PP0020 1 1 1155.504780 B 313.063369 3.69 0.0002 inv*PP0020 1 2 0.000000 B . . . inv*PP0020 2 1 0.000000 B . . . inv*PP0020 2 2 0.000000 B . . . inv*aidsoc 1 1 2726.814022 B 1148.625134 2.37 0.0176 inv*aidsoc 1 2 0.000000 B . . . inv*aidsoc 2 1 0.000000 B . . . inv*aidsoc 2 2 0.000000 B . . . The X'X matrix has been found to be singular, and a generalized inverse was used to solve the normal equations. Terms whose estimates are followed by the letter 'B' are not uniquely estimable Standardisation - Total catpredit Mean 1284.54 GLM MULTIVARIÉ – DÉPENSES DE PREMIÈRE LIGNE Essai 1 - en mettant toutes les intéractions possibles Class Level Information Class Levels Values age 7 1-4 ans 25-39 ans 40-64 ans 5-24 ans 65-74 ans 75-84 ans 85-+ ans im 2 1 2 inv 2 1 2 PP0020 2 1 2 prep 2 1 2 VPO 2 1 2 chom3 2 1 2 aidsoc 2 1 2 Number of Observations Read 21778 Number of Observations Used 21778
KCE Reports 85 S Médecine à l'acte / médecine au forfait - ANNEXES - 111 Source DF Sum of Squares Mean Square F Value Pr > F Model 63 486440889 7721284 26.08 F age 6 281744051.4 46957341.9 158.61
Page 1 and 2:
Comparaison du coût et de la quali
Page 3 and 4:
Comparaison du coût et de la quali
Page 5 and 6:
KCE Reports 85 S Médecine à l’a
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64: KCE Reports 85 S Médecine à l’a
Page 113: KCE Reports 85 S Médecine à l'act
Page 117 and 118: KCE Reports 85 S Médecine à l'act
Page 165 and 166:
KCE Reports 85 S Médecine à l'act
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
This page is left intentionally bla
Page 247 and 248:
KCE reports 1. Efficacité et renta
Page 249:
74. Oxygénothérapie Hyperbare: Ra
show all

Télécharger le supplément (250 p.) - KCE

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?